AbbVie Inc. (ABBV)

NYQ – Real Time Price. Currency in USD

249.02

-1.06 (-0.43%)

Market open: Aug 12, 2026, 10:14 AM EDT

249.90

-0.19 (-0.08%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

61.16B

56.33B

54.32B

58.05B

Cost of goods sold

-18.27B

-16.83B

-16.65B

-16.45B

Gross Profit

42.89B

39.50B

37.67B

41.61B

Operating expenses (excl. COGS)

-21.98B

-22.88B

-19.59B

-19.01B

Operating Income

20.91B

16.63B

18.08B

22.60B

Non-operating income, total

-14.32B

-12.91B

-11.83B

-9.13B

Pretax income

6.60B

3.72B

6.25B

13.48B

Equity in earnings

Taxes

-2.36B

570M

-1.38B

-1.63B

Non-controlling/minority interest

-7M

-8M

-10M

-9M

After tax other income/expense

-40M

-43M

-54M

Net income before discontinued operations

4.19B

4.24B

4.82B

11.78B

Discontinued operations

Net income

4.19B

4.24B

4.82B

11.78B

Dilution adjustment

Preferred dividends

AbbVie Inc. (ABBV)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AbbVie Inc. (ABBV)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

AbbVie Inc. (ABBV)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

AbbVie Inc. (ABBV)

Income Statement (Annual)

Income Statement (Annual)